Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2006-05-09
2006-05-09
Housel, James (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C530S350000
Reexamination Certificate
active
07041299
ABSTRACT:
A vaccine against Newcastle Disease contains one or more mutant immunogens of the NDW strain. The mutant immunogen lacks the antigenic binding site on the F glycoprotein which is recognized by the monoclonal antibody mAb 54. Reagent kits and assay methods help to distinguish vaccinated members of a poultry flock from those that may have been infected with wild-type Newcastle Disease virus.
REFERENCES:
patent: 5149530 (1992-09-01), van Wiltenburg
patent: 5250298 (1993-10-01), Gelb, Jr.
patent: 5733556 (1998-03-01), Schrier et al.
patent: 5750111 (1998-05-01), Schrier
patent: 6348197 (2002-02-01), Davelaar
patent: 6719979 (2004-04-01), Peeters et al.
patent: 2004/0043035 (2004-03-01), Mebatsion et al.
patent: WO 9902695 (1999-01-01), None
patent: WO 02/36617 (2002-05-01), None
Mebatsion, T. et al. Newcastle Disease Virus (NDV) Marker Vaccine: an Immunodominant Epitope on the Nucleoprotein Gene of NDV Can Be Deleted or Reaplcaed by a Foreign Epitope (Oct. 2002) Journal of Virology, 76(20): 10138-10146.
Peeters, B. et al. Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals (2001) Vaccine, 19:1616-1627.
J. gen. Virol. (1989), 70, 3105-3109, Printed in Great Britain, Location of Neutralizing Epitopes on the Fusion Protein of Newcastle Disease Virus Strain Beaudette C., K. Yusoff, et al.
Alexander Dennis John
Brown Ian Hamer
Collins Michael Sinclair
Geerligs Harmen J.
Housel James
Levis John F.
Salvoza M. Franco
Wyeth
LandOfFree
Escape mutants of newcastle disease virus as marker vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Escape mutants of newcastle disease virus as marker vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Escape mutants of newcastle disease virus as marker vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3632597